The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF ...

The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.

Philips Cardiac Workstation July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution ...

Cambridge, Mass.-based Royal Philips (NYSE: PHG), a global leader in health technology, today announced the launch of the Philips ECG AI Marketplace, a platform that gives cardiac care teams access to ...

Study findings published in the Annals of Family Medicine show high diagnostic performance of these technologies ...

Researchers at the German Centre for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of heart failure that has so far been difficult to treat. Prof. Johannes Backs, ...

A 74-year-old woman develops haemolytic anaemia and stress cardiomyopathy after a tick bite, highlighting a rare cardiac complication of babesiosis.

Patients with overweight or obesity and heart failure with preserved ejection fraction that have unintentional weight loss have worse outcomes.

An artificial intelligence model developed by Mayo Clinic and Ultromics accurately screens for cardiac amyloidosis using a ...

A small, hairy, toxic version of the cucumbers found in the produce aisle does have an advantage over its more palatable cousins — a feat of ballistic seed dispersal.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced a strategic restructuring plan ...

A new study shows that people with a type of heart failure called HFpEF (heart failure with preserved ejection fraction) are ...